News

Jazz Pharmaceuticals plc announced that the company has signed a new research collaboration agreement with Redx Pharma plc to discover and develop drug candidates for two cancer targets…
Read More...

Takeda Pharmaceutical Company Limited announced results from the Phase 3 TOURMALINE-MM2 trial evaluating the addition of NINLARO (ixazomib) to lenalidomide and dexamethasone versus…
Read More...

GlaxoSmithKline plc and Innoviva, Inc. announced the US Food and Drug Administration (FDA) has approved a new indication for Trelegy Ellipta (fluticasone furoate / umeclidinium /…
Read More...

AgeX Therapeutics, Inc. a company focused on developing and commercializing innovative therapeutics for human aging, and Lineage Cell Therapeutics, Inc. a clinical-stage biotechnology…
Read More...

Exscientia and Huadong Medicine announced that the companies have entered into a co-development partnership to accelerate the discovery of breakthrough small-molecule therapeutics…
Read More...

SciBite, the award-winning semantic technology company, announced the launch of SciBiteAI, a state-of-the-art Artificial Intelligence software platform for leveraging machine learning…
Read More...

Exelixis, Inc. and NBE-Therapeutics announced a partnership to discover and develop multiple antibody-drug conjugates (ADCs) for oncology applications by leveraging NBE’s unique…
Read More...

AnGes, Inc. announced a collaboration agreement with Brickell Biotech, Inc. a clinical-stage pharmaceutical company, through which Brickell has the right to develop AnGes’ proprietary…
Read More...

Mylan N.V. announced an agreement to acquire the related intellectual property and commercialization rights of Aspen Pharmacare Holdings Limited's thrombosis business in Europe for EUR…
Read More...

Immune Regulation Ltd, a US and UK based clinical stage biotechnology company, announced that it has received a notice of allowance from the U.S. Patent and Trademark Office (USPTO) for…
Read More...

AnHeart Therapeutics, Co., Ltd. a clinical stage oncology company focused on underserved patients in global markets, has through its subsidiary AnHeart Therapeutics Inc. entered into…
Read More...

Grifols announced it has entered into a transaction to acquire the remaining equity of Alkahest, Inc. in exchange for a total price of $146 million, on a debt-free basis. No additional…
Read More...

Destiny Pharma plc, a clinical stage biotechnology company focused on the development of novel, hospital infection prevention treatments that address the global challenge of…
Read More...

IcanoMAB, a privately-funded biotech company focusing on the pre-clinical and clinical development of novel precision canonical antibodies for the treatment of cancer, immune-system…
Read More...

Kite, a Gilead Company announced that it has submitted a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug Administration (FDA) for Yescarta (axicabtagene…
Read More...

AbbVie and I-Mab announced that AbbVie and I-Mab have signed a broad, global collaboration agreement for the development and commercialization of lemzoparlimab (also known as TJC4), an…
Read More...

Ehave, Inc. a provider of digital therapeutics delivering evidence-based therapeutic interventions to patients, announced it is entering into a licensing agreement with a telemedicine…
Read More...

PPD, Inc. and Lupus Therapeutics (LT), an affiliate of the Lupus Research Alliance known for its lupus clinical trials expertise, have entered into a collaboration to expand and enhance…
Read More...

On 2 September, WHO published guidance for clinicians and health care decision-makers on the use of corticosteroids in patients with COVID-19. We recommend systemic corticosteroids…
Read More...

Sanofi and GSK announce the start of the Phase 1/2 clinical trial for their adjuvanted COVID-19 vaccine. The vaccine candidate, developed in partnership by Sanofi and GSK, uses the same…
Read More...